177 related articles for article (PubMed ID: 2503296)
1. Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation.
van Uem JF; Hsiu JG; Chillik CF; Danforth DR; Ulmann A; Baulieu EE; Hodgen GD
Contraception; 1989 Aug; 40(2):171-84. PubMed ID: 2503296
[TBL] [Abstract][Full Text] [Related]
2. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
Collins RL; Hodgen GD
J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
[TBL] [Abstract][Full Text] [Related]
4. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
6. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
[TBL] [Abstract][Full Text] [Related]
9. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
10. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
11. Mifepristone: a potential contraceptive.
Heikinheimo O; Archer DF
Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
[TBL] [Abstract][Full Text] [Related]
12. Contraceptive potential of an antiprogestin ZK 98.734: reversal of ZK 98.734--induced blockade of folliculogenesis with FSH and LH and their differential effects in bonnet monkeys.
Puri CP; Katkam RR; Vadigoppula AD; Gopalakrishnan K; Elger WA; Billimoria FR; Patil RK
Indian J Exp Biol; 1992 Nov; 30(11):987-95. PubMed ID: 1293045
[TBL] [Abstract][Full Text] [Related]
13. Inhibin activity of preovulatory follicles of gonadotropin-treated and untreated women.
Channing CP; Tanabe K; Jones GS; Jones HW; Lebech P
Fertil Steril; 1984 Aug; 42(2):243-8. PubMed ID: 6430724
[TBL] [Abstract][Full Text] [Related]
14. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Ghosh D; Nayak NR; Sengupta J
Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
[TBL] [Abstract][Full Text] [Related]
15. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
[TBL] [Abstract][Full Text] [Related]
16. Effects of an antiprogesterone agent, RU-486, on the menstrual cycle of the rhesus monkey.
Shortle B; Dyrenfurth I; Ferin M
J Clin Endocrinol Metab; 1985 Apr; 60(4):731-5. PubMed ID: 3972971
[TBL] [Abstract][Full Text] [Related]
17. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
18. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
[TBL] [Abstract][Full Text] [Related]
19. Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys.
Collins RL; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1984 Oct; 59(4):727-33. PubMed ID: 6434577
[TBL] [Abstract][Full Text] [Related]
20. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
